Treatments that target a fragment of the mutant protein that causes Huntington's disease might be more effective than ...
A protein already targeted by FDA-approved cancer drugs may also help the body fight influenza, according to new research from The Jackson Laboratory (JAX). Published in Cell Reports, the study found ...
Researchers have created nanoparticles that can remove disease-driving proteins while also delivering a chemotherapeutic or ...
Acurastem received a grant to develop ALS therapies targeting SYF2, a regulator of TDP-43, in collaboration with academic research teams.
A long-running debate in vaccine design revolves around whether a vaccine should be optimized to prevent the virus from ...
Hosted on MSN
Targeting key proteins in fight against ALS
Northwestern Medicine scientists have zeroed in on a cellular gatekeeper that may hold promise for treating abnormal protein accumulation in neurodegenerative diseases, according to a study published ...
An estimated 20 percent of adults in the US experience chronic pain. 1 To help patients manage their condition, clinicians have employed one main type of pain-relieving drug: opioids. With their ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results